Nodal marginal zone lymphoma: Clinical features, diagnosis, management and treatment

被引:13
|
作者
Tadmor, Tamar [1 ,2 ]
Polliack, Aaron [3 ,4 ]
机构
[1] Bnai Zion Med Ctr, Hematol Unit, 47 Golomb St, IL-31048 Haifa, Israel
[2] Technion, Ruth & Bruce Rappaport Fac Med, Haifa, Israel
[3] Hadassah Univ Hosp, Dept Hematol, Jerusalem, Israel
[4] Hebrew Univ Jerusalem, Sch Med, Jerusalem, Israel
关键词
Nodal marginal zone lymphoma; NMZL; Clinical features; Treatment Diagnosis; B-CELL LYMPHOMA; NON-HODGKIN-LYMPHOMA; CLINICOPATHOLOGICAL FEATURES; PROGNOSTIC-FACTORS; PHASE-II; RITUXIMAB; INDOLENT; DISTINCT; OUTCOMES; THERAPY;
D O I
10.1016/j.beha.2016.08.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nodular marginal zone lymphoma (NMZL) is a small B-cell lymphoma involving only lymph nodes and is the least common form of MZL constituting about 10% of cases. Patients usually present with advanced disease which must be distinguished from extranodal MZL with lymph node spread. NMZL shares cytological and immunophenotypic features with MALT and splenic MZL, but has a less favorable prognosis than these two categories. It occurs mostly in adults and pediatric cases are rare. Different therapeutic approaches have been used in NMZL, but because of the small patient numbers involved, more definitive treatment is still anticipated. Recent studies suggest that it probably represents a separate entity within the broader indolent lymphoma category. In NMZL there is an emerging need to utilize novel agents, already available for indolent lymphomas. Prospective studies are required to evaluate their therapeutic efficacy for NMZL in the future. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:92 / 98
页数:7
相关论文
共 50 条
  • [1] Nodal marginal zone lymphoma
    Angelopoulou, Maria K.
    Kalpadakis, Christina
    Pangalis, Gerassimos A.
    Kyrtsonis, Marie-Christine
    Vassilakopoulos, Theodoros P.
    LEUKEMIA & LYMPHOMA, 2014, 55 (06) : 1240 - 1250
  • [2] Diagnosis and treatment of marginal zone lymphoma
    Cogliatti, Sergio
    Bargetzi, Mario
    Bertoni, Francesco
    Hitz, Felicitas
    Lohri, Andreas
    Mey, Ulrich
    Papachristofilou, Alexandros
    Taverna, Christian
    Zucca, Emanuele
    Renner, Christoph
    SWISS MEDICAL WEEKLY, 2016, 146 : 1S - 12S
  • [3] Splenic marginal zone lymphoma: disease features and management
    Matutes, Estella
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (06) : 735 - 745
  • [4] Optimizing therapy for nodal marginal zone lymphoma
    Thieblemont, Catherine
    Molina, Thierry
    Davi, Frederic
    BLOOD, 2016, 127 (17) : 2064 - 2071
  • [5] Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?
    Kalpadakis, Christina
    Pangalis, Gerassimos A.
    Vassilakopoulos, Theodoros P.
    Sachanas, Sotirios
    Angelopoulou, Maria K.
    LEUKEMIA & LYMPHOMA, 2014, 55 (07) : 1463 - 1470
  • [6] Marginal zone lymphoma: 2023 update on diagnosis and management
    Cheah, Chan Y.
    Seymour, John F.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (10) : 1645 - 1657
  • [7] Clinicopathologic Features of CD5-Positive Nodal Marginal Zone Lymphoma
    Jaso, Jesse Manuel
    Yin, C. Cameron
    Wang, Sa A.
    Miranda, Roberto N.
    Jabcuga, Christine E.
    Chen, Lei
    Medeiros, L. Jeffrey
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 140 (05) : 693 - 700
  • [8] Marginal Zone Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up
    Kandil, Magdy
    Alhashmi, Hani
    Alzahrani, Musa
    Azi, Ayman Alhej
    Motabi, Ibraheem
    Dada, Reyad
    Al-Mansour, Mubarak
    Sagheir, Ahmed
    SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2019, 7 (03) : 202 - 208
  • [9] Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment
    Di Rocco, Alice
    Petrucci, Luigi
    Assanto, Giovanni Manfredi
    Martelli, Maurizio
    Pulsoni, Alessandro
    CANCERS, 2022, 14 (07)
  • [10] Retrospective characterization of nodal marginal zone lymphoma
    Stuver, Robert
    Drill, Esther
    Qualls, David
    Okwali, Michelle
    Batlevi, Connie Lee
    Caron, Philip C.
    Dogan, Ahmet
    Epstein-Peterson, Zachary D.
    Falchi, Lorenzo
    Hamlin, Paul A.
    Horwitz, Steven M.
    Imber, Brandon S.
    Intlekofer, Andrew M.
    Johnson, William T.
    Khan, Niloufer
    Kumar, Anita
    Lahoud, Oscar B.
    Lue, Jennifer Kimberly
    Matasar, Matthew J.
    Moskowitz, Alison J.
    Noy, Ariela
    Owens, Colette N.
    Polomba, M. Lia
    Schoder, Heiko
    Vardhana, Santosha A.
    Yahalom, Joachim
    Zelenetz, Andrew D.
    Salles, Gilles
    Straus, David J.
    BLOOD ADVANCES, 2023, 7 (17) : 4838 - 4847